• Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

  • Aug 25 2024
  • Length: 11 mins
  • Podcast

Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

Listen for free

View show details

  • Summary

  • Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients.

    Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition.

    You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology.

    Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

    Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available